Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus.
about
Risk factors in coronary atherosclerosis athero-inflammation: the meeting pointWhy is coronary collateral growth impaired in type II diabetes and the metabolic syndrome?Lipid composition of cell membranes and its relevance in type 2 diabetes mellitusVascular Effects of Dietary Advanced Glycation End ProductsERK5 Mediated Signalling in Diabetic RetinopathyMembrane flexibility, free fatty acids, and the onset of vascular and neurological lesions in type 2 diabetesAtorvastatin helps preserve pancreatic β cell function in obese C57BL/6 J mice and the effect is related to increased pancreas proliferation and amelioration of endoplasmic-reticulum stress.Activated platelets from diabetic rats cause endothelial dysfunction by decreasing Akt/endothelial NO synthase signaling pathwayIncreased cytochrome P4502E1 expression and altered hydroxyeicosatetraenoic acid formation mediate diabetic vascular dysfunction: rescue by guanylyl-cyclase activation.Effect of Lacidipine on Blood Pressure and Endothelial Function in Mild-to-Moderate Essential Hypertension Patients With Diabetes in KoreaType 2 diabetes elicits lower nitric oxide, bradykinin concentration and kallikrein activity together with higher DesArg(9)-BK and reduced post-exercise hypotension compared to non-diabetic conditionNovel soy germ pasta improves endothelial function, blood pressure, and oxidative stress in patients with type 2 diabetes.Inhibition of Prostaglandin Transporter (PGT) Promotes Perfusion and Vascularization and Accelerates Wound Healing in Non-Diabetic and Diabetic RatsThe Relationship between Multiple Health Behaviours and Brachial Artery ReactivityXiaokening stimulates endothelial nitric oxide release in diabetic rats.MicroRNA-181b regulates NF-κB-mediated vascular inflammation.Folic acid: a marker of endothelial function in type 2 diabetes?Dyslipidemia associated with poor glycemic control in type 2 diabetes mellitus and the protective effect of metformin supplementation.Improvement of vascular function by acute and chronic treatment with the PDE-5 inhibitor sildenafil in experimental diabetes mellitus.Effect of diabetic duration on hemorheological properties and platelet aggregation in streptozotocin-induced diabetic ratsType II diabetes mellitus and cardiovascular risk factors: Current therapeutic approachesBenefits of tight blood pressure control in diabetic patients with hypertension: importance of early and sustained implementation of effective treatment strategiesFactors of cardiovascular risk in patients with type 2 diabetes and incipient nephropathyLaminar shear stress inhibits lipid peroxidation induced by high glucose plus arachidonic acid in endothelial cells.Flexible initial dosing of atorvastatin based upon initial low-density lipoprotein cholesterol levels in type 2 diabetic patientsGlycemic status and brain injury in older individuals: the age gene/environment susceptibility-Reykjavik study.Elevated epidermal growth factor receptor phosphorylation induces resistance artery dysfunction in diabetic db/db mice.Endothelial microRNAs and atherosclerosis.NO/peroxynitrite dynamics of high glucose-exposed HUVECs: chemiluminescent measurement and computational model.Protective effects of heparin on endothelial cells in sepsisGlycemic Control during Coronary Artery Bypass Graft Surgery.High glucose attenuates VEGF expression in rat multipotent adult progenitor cells in association with inhibition of JAK2/STAT3 signalling.Impaired coronary collateral growth in the metabolic syndrome is in part mediated by matrix metalloproteinase 12-dependent production of endostatin and angiostatin.Protective effect of sitagliptin and rosuvastatin combination on vascular endothelial dysfunction in type-2 diabetes.
P2860
Q24793107-3C1938E5-2EE3-400C-8492-7A5851FF09B7Q27015707-2B0B976B-20AB-4BF7-91F9-E344A48A4411Q27016081-D1C7EB30-102B-414A-A7A9-3AB3FB93BFAAQ28081090-53BF041A-7920-4006-81A9-60B6AE3FF541Q28083251-9030FE1A-C910-482C-9FBF-1C31DB4FCD39Q28083976-A1B632C4-FE2B-4FCD-B9DC-6504721E79DEQ33835644-E28715AD-5AB7-43EC-AAE3-E7DF18BC505DQ33927945-702F3EEF-E712-4FB2-B2D9-1669016348F2Q34024378-D9589208-D177-4954-985A-70DC9EE9CC88Q34512541-5F7397A1-BBB0-404A-B8F2-04ED590B811FQ35050624-C71C3A6B-4293-49AD-AE7A-45AA700E0456Q35179942-F985A6A6-0E6D-4F5A-BC51-F1F513A9AAF4Q35730280-4445F302-E113-4DF8-90EB-668F13E9EBEEQ35821297-040B83B4-529B-4FD5-8906-655F605240F5Q35905038-48A18DBD-4B4C-4839-8133-4AB2B2117F09Q36005391-4B3AABF8-D5D2-4820-A7C7-0E612FBF4A7EQ36012812-207FF47F-5AC2-4DC5-BF19-ED7EF649D727Q36336398-2C07E0C0-0088-4827-A035-3F2DFF3B5A84Q36495117-A289618B-C58B-4C46-895A-8ECFA69179D8Q36602601-B689162C-BD47-4843-B87B-838DE88B4AFDQ36608474-1D6D5AC4-59DF-4F00-B19E-82E42889C193Q36783870-436B602F-FDA2-4413-84A7-A06A31F26025Q36966203-F7A9FB5D-AD85-43FF-9E82-7DEB03D8124CQ37038944-4D30C2D9-73FC-4E49-863B-C40F18B30421Q37203549-052D4FB4-DFD4-4AA6-AE17-A2886F5ED6F2Q37319238-271BC11A-F530-4033-84DE-D2D84F2D20F1Q37379205-422E0F6A-D666-4A3F-A8B5-5B2431E9CC2BQ37384227-E53BD580-2334-4024-9708-641032266DCCQ39861568-566356E0-EFC6-4A81-82E0-08FB3C238F35Q41638739-D884FA36-6EE9-4E1D-932C-18333FFF91F5Q41731510-70AB8787-6C61-4E65-9E69-295F8DF0BE90Q41966597-008B8B64-D9DA-4376-9EE7-168DFD74B148Q42571891-5F73A45C-220A-4EFF-859C-ECCFFFC8E4C2Q43182745-F2D25BB4-BF57-463E-A080-9A689B4678D1
P2860
Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Endothelial dysfunction and ty ...... s in type 2 diabetes mellitus.
@ast
Endothelial dysfunction and ty ...... s in type 2 diabetes mellitus.
@en
Endothelial dysfunction and ty ...... s in type 2 diabetes mellitus.
@nl
type
label
Endothelial dysfunction and ty ...... s in type 2 diabetes mellitus.
@ast
Endothelial dysfunction and ty ...... s in type 2 diabetes mellitus.
@en
Endothelial dysfunction and ty ...... s in type 2 diabetes mellitus.
@nl
prefLabel
Endothelial dysfunction and ty ...... s in type 2 diabetes mellitus.
@ast
Endothelial dysfunction and ty ...... s in type 2 diabetes mellitus.
@en
Endothelial dysfunction and ty ...... s in type 2 diabetes mellitus.
@nl
P2093
P1476
Endothelial dysfunction and ty ...... s in type 2 diabetes mellitus.
@en
P2093
Kearney-Schwartz A
P304
P433
P577
2001-09-01T00:00:00Z